本页面由Tiger Trade Technology Pte. Ltd.提供服务

Dianthus Therapeutics Inc.

77.58
-3.9900-4.89%
盘后:77.580.00000.00%19:30 EDT
成交量:131.54万
成交额:1.03亿
市值:43.39亿
市盈率:-18.86
高:81.46
开:81.42
低:77.25
收:81.57
52周最高:117.88
52周最低:32.22
股本:5,593.44万
流通股本:5,585.01万
量比:1.46
换手率:2.36%
股息:- -
股息率:- -
每股收益(TTM):-4.1130
每股收益(LYR):-4.2037
净资产收益率:-26.07%
总资产收益率:-17.69%
市净率:3.70
市盈率(LYR):-18.46

数据加载中...

2024/12/12

重要事件披露

Form 8-K - Current report
2024/12/03

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/22

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/10/11

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/10/07

SEC问询函

Form CORRESP - Correspondence
2024/10/07

SEC问询函

Form CORRESP - Correspondence
2024/09/16

重要事件披露

Form 8-K - Current report
2024/09/12

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/08

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/08

重要事件披露

Form 8-K - Current report
2024/06/06

重要事件披露

Form 8-K - Current report
2024/05/28

重要事件披露

Form 8-K - Current report
2024/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/04/01

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]